Toxic multinodular goiter screening

Jump to navigation Jump to search

Toxic multinodular goiter Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Toxic multinodular goiter from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Toxic multinodular goiter screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Toxic multinodular goiter screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Toxic multinodular goiter screening

CDC on Toxic multinodular goiter screening

Toxic multinodular goiter screening in the news

Blogs on Toxic multinodular goiter screening

Directions to Hospitals Treating Toxic multinodular goiter

Risk calculators and risk factors for Toxic multinodular goiter screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aravind Reddy Kothagadi M.B.B.S[2]

Overview

Toxic multinodular goiter is diagnosed by a physical examination which reveals nodules in the throat, rapid heart rate, diaphoresis, and tremors. Screening includes testing for elevated T3 and T4 hormone levels that indicate hyperthyroidism. TSH assays are the best initial screening tool for hyperthyroidism.

Screening

The screening for toxic multinodular goiter are as follows:[1][2][3][4]

  • Toxic multinodular goiter is diagnosed by a physical examination which reveals nodules in the throat, rapid heart rate, diaphoresis, and tremors.
  • Screening includes testing for elevated T3 and T4 hormone levels that indicate hyperthyroidism.
  • TSH assays are the best initial screening tool for hyperthyroidism. Patients with TNG will have suppressed TSH levels.
  • Low levels of thyroid-stimulating hormone (TSH) are suggestive of hyperthyroidism
  • An isolated increase in T4 is observed in iodine-induced hyperthyroidism or patients taking propranolol, corticosteroids, radiocontrast agents, amiodarone.
  • 5-46% of patients with toxic nodules have normal free T4 levels with an elevated T3, this is called T3 toxicosis.
  • Overactive nodules are found on ultrasound scans of the thyroid to create images of the thyroid, which can reveal the conjunction with a special radioactive iodine test that involves swallowing a pill prior to special scans.
  • The normal range for total T3 and T4 levels may vary for each and every individual; especially in case of people with nonthyroidal illness with decreased T3 levels.

References

  1. "Toxic multinodular goitre. Personal case histories and literature review. - PubMed - NCBI".
  2. "Hyperfunctioning thyroid nodules. - PubMed - NCBI".
  3. "Relationship between metabolic syndrome and multinodular non-toxic goiter in an inpatient population from a geographic area with moderate iodine de... - PubMed - NCBI".
  4. "Thyroid cancer in toxic and non-toxic multinodular goiter. - PubMed - NCBI".

Template:WH Template:WS